Clinical Trials Browser

Interventional × Blood Specimen Collection × Genitourinary × Clear all

NCT07463508 2026-03-11

TG-BIL

Phase NA Recruiting

Testicular Neoplasms

NCT07406646 2026-02-12

EXO-RENAL1

Phase NA Completed

Carcinoma, Renal Cell

NCT06492122 2026-01-29

ProTACT

Phase 1 Recruiting

Metastatic Castration-resistant Prostate Cancer

NCT06600802 2025-12-31

PSMA-PRED

Phase NA Recruiting

Castration-resistant Metastatic Prostate Cancer

NCT07054346 2025-12-01

LUTACT

Phase 1 Recruiting

Disease, Prostatic Neoplasms

NCT04167969 2025-10-14

The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer

Phase 1 Recruiting

Prostatic Neoplasms

NCT06435546 2025-09-16

AdOTAC

Phase NA Recruiting

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT05141383 2025-09-08

HOPE

Phase NA Completed

Disease, Prostatic Neoplasms

NCT05011188 2025-08-27

FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1/2 Active not recruiting

Prostatic Neoplasms

NCT05151341 2025-07-24

URODX-FGFR3

Phase NA Completed

Urinary Bladder Neoplasms, Disease, Neoplasms

NCT06942104 2025-07-18

Imaging of Solid Tumors Using 18F-TRX

Phase 1 Recruiting

CNSGenitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Glioma, Neoplasm Metastasis, Prostatic Neoplasms

NCT06896162 2025-07-11

PROGRESS

Phase NA Recruiting

BreastGastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT04581109 2025-07-10

EPIDROP

Phase NA Recruiting

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT06904313 2025-06-04

Ultralow Dose PET Imaging for PSMA Expression

Phase 2 Recruiting

Prostatic Neoplasms

NCT04732156 2024-02-28

CHANGE

Phase NA Recruiting

Prostatic Neoplasms

NCT06020651 2023-08-31

VICKI

Phase NA Unknown

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Neoplasms, Vascular Diseases, Atherosclerosis

NCT04324983 2023-04-12

BioPoP

Phase NA Completed

Prostate Cancer Recurrent

NCT03987568 2022-12-21

Characterize Tumor Hypoxia by Magnetic Resonance Imaging

Phase NA Withdrawn

Prostatic Neoplasms

NCT05426317 2022-06-22

Onco-PDL1s/B2M

Phase NA Unknown

DermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Melanoma

NCT05241561 2022-06-01

Cabo-POLARIS

Phase 2 Not yet recruiting

Kidney Neoplasms

NCT02822404 2022-04-25

CysPed

Phase NA Completed

Kidney Diseases

NCT02235142 2022-01-20

AndroCan

Phase NA Completed

Prostatic Neoplasms

NCT04556916 2022-01-04

PROLIPSY

Phase NA Recruiting

Prostatic Neoplasms

NCT03787056 2021-07-16

ONCOPRO

Phase NA Recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Lymphoma, B-Cell, Endometrial Neoplasms

NCT04774133 2021-03-01

The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients.

Phase NA Unknown

Prostatic Neoplasms

NCT03331367 2020-08-07

Investigating and Characterizing the Immune Response to Prostate Cancer

Phase NA Completed

Prostatic Neoplasms

NCT02963155 2020-01-10

NKPROSTATE

Phase NA Unknown

Neoplasm Metastasis, Prostatic Neoplasms

NCT03185039 2020-01-10

Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents

Phase NA Unknown

Kidney Neoplasms

NCT00798876 2019-05-07

Low-Fat Fish Oil Diet for Prostate Cancer Prevention

Phase NA Completed

Prostatic Neoplasms

NCT01598038 2017-07-28

Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma

Phase NA Terminated

Carcinoma, Renal Cell, Neoplasms

NCT00957606 2011-04-13

Osteoporosis

Phase 3 Unknown

Osteoporosis, Prostatic Neoplasms